Back
Apellis Pharmaceuticals Stock Predictions
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$17.80
Seasonality Move:
5.74%
7 Day Trial
ALL ACCESS PASS
$
7
Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Apellis Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 12% based on the past 7 years of stock performance.
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Apellis Pharmaceuticals Stock Undervalued?The current Apellis Pharmaceuticals [APLS] share price is $17.78. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 12% based on the past 7 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
43.99
52-Week Low:
16.10
Prediction Charts
Market Cap:
2.2B
Price in USD:
17.78
Volume:
1.7M
Beta:
0.94
Technical Analysis
SMA50:
20.11
SMA100:
24.60
SMA200:
28.63
52-Wk Change:
-59.22%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?Yes, Apellis Pharmaceuticals is a publicly traded company.
-
What is the Apellis Pharmaceuticals stock quote today?The Apellis Pharmaceuticals stock price is 17.78 USD today.
-
How to buy Apellis Pharmaceuticals stock online?You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-5 | 20.30 | 19.98 | 20.59 | 19.81 |
| May-6 | 19.76 | 19.12 | 20.18 | 18.99 |
| May-7 | 17.16 | 17.99 | 19.32 | 16.65 |
| May-8 | 17.81 | 17.81 | 18.32 | 17.35 |
| May-9 | 17.52 | 17.30 | 18.10 | 17.24 |
| May-12 | 17.76 | 17.52 | 18.06 | 17.27 |
| May-13 | 17.54 | 17.28 | 17.64 | 17.16 |
| May-14 | 17.25 | 16.70 | 17.26 | 16.41 |
| May-15 | 16.69 | 16.36 | 16.74 | 16.10 |
| May-16 | 16.35 | 17.45 | 17.79 | 16.34 |
| May-19 | 17.24 | 17.67 | 17.71 | 17.05 |
| May-20 | 17.69 | 18.51 | 19.02 | 17.41 |
| May-21 | 18.20 | 17.42 | 18.39 | 17.23 |
| May-22 | 17.14 | 17.78 | 17.87 | 17.07 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.